Socium Therapeutics announces that Prof. Joachim Fensterle has joined the company’s Scientific Advisory Board by socium | Jul 9, 2018 | NewsText will go here etc…
Socium Therapeutics acquires AEZS-120 and Salmonella typhi Ty21a immunotherapy platform from Aeterna Zentaris by socium | Jul 9, 2018 | NewsText will go here etc…..
